Cannabidiol In Patients With Treatment-resistant Epilepsy: An Open-label Interventional Trial
Zolgensma Benefits Observed in Presymptomatic SMA Patients March 28 2021 …
Read more
Cannabidiol In Patients With Treatment-resistant Epilepsy: An Open-label Interventional Trial